1.Clinical Reviews on 28 Patients with Ulcerative Colitis.
Myung Ju AHN ; Kyung Rang MIN ; Joon Soo HAHM ; Choon Suhk KEE ; Kyung Nam PARK
Korean Journal of Gastrointestinal Endoscopy 1987;7(1):19-26
The ulcerative colitis is a relatively common disease in the European and North American countries aince Dr. Wilks has first reported the cases in 1895, But in Korea, this disease is a rare entity and only a few case have been reported. However, rescently the diagnoetic methods for ulcerative colitis are much developed we have experienced 28 cases of ulcerative colitis which were diagnosed by endoscopy, barium enema exam and biopsy. Therefore a total of 28 patient with ulcerative colitis diagnosed and treated at the department of internal medicine of HYUH from June 1979 to June 1986 was reviewed. We obtained the results as follows; 1) The sex distribution assumed a ratio of 1 to 1.33 with 12 males and 16 females. 2) The age dietribution was relatively even but the majority of cases were between 5th and 6th decade (32.1%), 3) The most prominent clinical symptoms were rectal bleeding, abdominal pain, diarrhea, fever, wight loss and vomiting. 4) Significant laboratory findins were anemia, eleveited ESR, leukocytosis, positive stool OB, electrolyte imbalance and decreased serum albumin level. 5) As to the extent of disease determined by the barium enema examination and endoscopic exam., rectum or rectosigmoid colon is involved in majority of the cases (92.8%). 6) The endoscopic examination was performed in all 28 cases and showed significant findings such as ulceration, hyperemia, mucosal friability, bleeding etcs. 7) The barium enema examination was performed in 19 cases and showed positive findings such as ulceration, luminal narrowing, bowel shortening and rigidity in 17 cases. 8) 21 of 28 patients treated by medical therapy showed relatively improved but 4 of 28 patients was exacerbated or relapsed and one has expired.
Abdominal Pain
;
Anemia
;
Barium
;
Biopsy
;
Colitis, Ulcerative*
;
Colon
;
Diarrhea
;
Endoscopy
;
Enema
;
Female
;
Fever
;
Hemorrhage
;
Humans
;
Hyperemia
;
Internal Medicine
;
Korea
;
Leukocytosis
;
Male
;
Phenobarbital
;
Rectum
;
Serum Albumin
;
Sex Distribution
;
Ulcer*
;
Vomiting
2.Expression of C-type Natriuretic Peptide and Natriuretic Peptide Receptors in the Mouse Submandibular Glands Following Embryonic Development, Postnatal Differentiation and Aging.
Se Mi BOK ; Tak Heun KIM ; Kee Rang PARK ; Eui Sic CHO
Korean Journal of Anatomy 2005;38(4):325-336
C-type natriuretic peptide (CNP), a member of natriuretic peptide family, is mainly synthesized in the endothelium and central nervous system. But CNP is also involved in the growth and differentiation of other peripheral organs. Although we have reported the local synthesis and localization of CNP in the adult submandibular glands (SMG), it is not known that the expression and biological activity of CNP following the morphogenesis, differentiation and aging. This study aimed to examine the expression of CNP and its receptors in the developing and differentiating stages of mouse SMG, and the changes of biological activity of its receptors with aging. The SMG, obtained from 14, 16, 18 days-old embryos (E) and 1 day, 2 weeks, 1, 2, 12, and 24 month-old C57BL/6N mouse, were processed for RT-PCR, in situ hybridization, immunohistochemistry and cGMP assay. CNP was strongly expressed in the epithelial clusters of primitive SMG, which was maintained before birth but was markedly decreased after birth. CNP was localized in the intercalated duct and granular convoluted tubules of adult SMG, where NPRC was specifically expressed but NPRB was not. CNP mRNA was gradually decreased from E16 to 2 M but ANP mRNA was opposed. NPRB and NPRC were the same pattern of the expression of CNP but NPRA was weakly expressed. In addition, CNP mRNA was also expressed in the craniofacial tissues such as tooth germs, tongue, premaxilla and bone forming area in which NPRC was specifically expressed but NPRB was not. In the SMG of 2 M, the membrane of duct cells markedly produced cGMP by CNP whereas acini produced cGMP by ANP and BNP rather than CNP. The biological activity of cGMP production of SMG gradually decreased with age. cGMP production was dominant by CNP in SMG of 1M but was by ANP after 2M. These results shows that CNP may play roles both in the morphogenesis and differentiation via NPRC and in the maintenance of duct system via NPRB in the mouse SMG and that the biological activity of its receptors may decreased with aging.
Adult
;
Aging*
;
Animals
;
Atrial Natriuretic Factor
;
Central Nervous System
;
Child, Preschool
;
Embryonic Development*
;
Embryonic Structures
;
Endothelium
;
Female
;
Humans
;
Immunohistochemistry
;
In Situ Hybridization
;
Membranes
;
Mice*
;
Morphogenesis
;
Natriuretic Peptide, C-Type*
;
Parturition
;
Pregnancy
;
Receptors, Peptide*
;
RNA, Messenger
;
Submandibular Gland*
;
Tongue
;
Tooth Germ
3.A Case of Leptomeningeal Carcinomatosis on Superficial Spreading Carcinoma of the Stomach.
Kyung Rang MIN ; Seung Ku LEE ; Jun Soo HAM ; Jong Chul RHEE ; Min Ho LEE ; Dong Hoo LEE ; Choon Suhk KEE ; Kyung Nam PARK ; Eun Kyung HONG
Korean Journal of Gastrointestinal Endoscopy 1986;6(1):19-23
Meningeal carcinomatosis is an important neurological complication of systemic cancer, and is increasingly being recognized as a cause of reurologic disability in life. Also there is evidenee that the incidence of this form of metastasis is increasing. We reported a case of 52-year-old female patient, who was diagnosed as early gastric cancer by biopsy under gastrofiberscopy. Other Lab. findings were all normal range except high alkaline phosphatase level. And then performed Billroth II operation. On 7th post-operative day, she was encountered severe headache and insomnia. Abnormal neurologic signs and subjective symptoms were developed and progressed, Repeated lumbar punture was done and CSF was examed. There findings were abnormal, but no specific finding of certain disease. She died of severe neurologic deficit and sudden respiratory arrest. Autopsy was done, and confirmed leptomeningeal carcinomatosis.
Alkaline Phosphatase
;
Autopsy
;
Biopsy
;
Female
;
Gastroenterostomy
;
Headache
;
Humans
;
Incidence
;
Meningeal Carcinomatosis*
;
Middle Aged
;
Neoplasm Metastasis
;
Neurologic Manifestations
;
Reference Values
;
Sleep Initiation and Maintenance Disorders
;
Stomach Neoplasms
;
Stomach*
4.Differentiated Thyroid Carcinoma of Children and Adolescents: 27-Year Experience in the Yonsei University Health System.
Seulkee PARK ; Jun Soo JEONG ; Haeng Rang RYU ; Cho Rok LEE ; Jae Hyun PARK ; Sang Wook KANG ; Jong Ju JEONG ; Kee Hyun NAM ; Woong Youn CHUNG ; Cheong Soo PARK
Journal of Korean Medical Science 2013;28(5):693-699
Thyroid carcinomas are uncommon in childhood and adolescence. The aim of this study was to analyze clinical features and clinical outcomes of thyroid cancer in the pediatric population treated in the Yonsei University Health System. From September 1982 to June 2009, 90 patients (75 females, 15 males; female:male ratio of 5:1) with differentiated thyroid carcinoma were identified in our institute. The mean age at diagnosis was 15.8 yr old (range 4.8-19.9 yr). Cervical masses were most common clinical manifestations at diagnosis in 65 patients (72.2%). Forty-two patients underwent less than total thyroidectomy and 18 patients underwent total thyroidectomy. Thirty patients (33.3%) had lateral neck lymph node metastasis and seven patients (7.8%) had lung metastasis at the time of surgery. Among the 90 patients, recurrence occurred in 14 patients (15.5%). Mean follow-up period for patients with differentiated thyroid carcinoma was 81.6 months (13-324 months). No patients died of differentiated thyroid carcinoma. Patients with differentiated thyroid carcinoma who were < 20-yr-of-age were present with aggressive local disease and a high frequency of lymph node and distant metastasis. It is recommended that pediatric thyroid cancer should be managed mostly using proper surgical approach with thyroidectomy and lymph node dissection when indicated.
Adolescent
;
Age Factors
;
Carcinoma/*pathology/surgery
;
Child
;
Child, Preschool
;
Female
;
Follow-Up Studies
;
Hospitals, University
;
Humans
;
Iodine Radioisotopes/therapeutic use
;
Lung Neoplasms/diagnosis/secondary
;
Lymph Node Excision
;
Lymph Nodes/surgery
;
Lymphatic Metastasis
;
Male
;
Recurrence
;
Survival Rate
;
Thyroid Neoplasms/*pathology/radiotherapy/surgery
;
Thyroidectomy
;
Young Adult
5.The Clinicopathological Features and Postoperative Complications of Completion Thyroidectomy for Recurrent Papillary Thyroid Carcinoma.
Chang Woo KIM ; So Hee LEE ; Haeng Rang RYU ; Kang Young RHEE ; Sang Wook KANG ; Jong Joo JUNG ; Kee Hyun NAM ; Hang Seok CHANG ; Woong Youn CHUNG ; Cheong Soo PARK
Korean Journal of Endocrine Surgery 2009;9(3):161-166
PURPOSE: A completion thyroidectomy after less than total thyroidectomy is needed for the treatment of recurrent papillary thyroid carcinoma (PTC). The aim of this study is to evaluate the clinicopathological features and the postoperative complications of completion thyroidectomy for patients with recurrent PTC. METHODS: A total 94 PTC patients who had undergone prior less than total thyroidectomy underwent completion thyroidectomy for recurrence from March 1986 to June 2009. We retrospectively analyzed the clinicopathological features and postoperative complications. RESULTS: At the initial operation, the patients' mean age was 38.2 years old. Central node metastasis was found in 37 cases and extrathyroidal invasion was found in 12 cases. The mean interval time between the initial operation to the completion thyroidectomy was 76.6 months. Fifty six patients underwent completion thyroidectomy only and 38 underwent a completion thyroidectomy combined with a modified radical neck dissection. In the combined group, central neck node metastasis and extrathyroidal invasion at the time of the initial operation were significantly more frequent than those in the completion thyroidectomy only group. The postoperative complications were 14 cases of transient hypocalcemia and 8 cases of permanent hypocalcemia and there were no significant differences between the two groups. CONCLUSION: When performing completion thyroidectomy, it is important to check the lateral neck nodes for metastasis when central neck node metastasis or extrathyroidal invasion were present at the initial operation, and this can be done safely without severe complications even though it is combined with modified radical neck dissection.
Humans
;
Hypocalcemia
;
Neck
;
Neck Dissection
;
Neoplasm Metastasis
;
Postoperative Complications*
;
Recurrence
;
Retrospective Studies
;
Thyroid Gland*
;
Thyroid Neoplasms*
;
Thyroidectomy*
6.A Study of Effective Unified Medical Language System Concept Indexing in Radiology Reports.
Jung Ae LEE ; Hwa Jeong SEO ; Kee Won KIM ; Mingoo KIM ; Seung Kwon HONG ; Yu Rang PARK ; Ju Han KIM
Journal of Korean Society of Medical Informatics 2004;10(3):295-302
OBJECTIVE: For the effective retrieval of clinical information, the elaborate indexing is essential. Two major types of indexing are the human indexing and the automatic or machine indexing. Human indexing shows higher quality but is time consuming, labor-intensive and inconsistent in term assignment activity. METHODS: Using the Unified Medical Language System (UMLS) MetaMap program, we mapped the free text from the diagnosis section of radiology reports into UMLS concepts. To improve the precision of UMLS concept indexing by MetaMap, we evaluated the UMLS subset mapping and semantic type filtering methods, determining the best combination for improved precision. RESULTS: After calculating the candidates from subset combinations, we obtained more enhanced results by semantic-type filtering. CONCLUSION: The results may be improved for the complete automation of indexing process.
Abstracting and Indexing as Topic*
;
Automation
;
Diagnosis
;
Humans
;
Semantics
;
Unified Medical Language System*
7.Clinical and Hematological Effects of Tocilizumab on Serum Hepcidin, Anemia Response and Disease Activity in Patients with Active Rheumatoid Arthritis.
Ki Jeong PARK ; Hye Mi JIN ; Young Nan CHO ; Jeong Hwa KANG ; Hyun Ju JUNG ; Ji Hyoun KANG ; Ji Eun KIM ; Yi Rang YIM ; Jeong Won LEE ; Kyung Eun LEE ; Dong Jin PARK ; Tae Jong KIM ; Shin Seok LEE ; Seung Jung KEE ; Yong Wook PARK
Journal of Rheumatic Diseases 2016;23(1):37-46
OBJECTIVE: The purpose of this study is to evaluate the clinical and hematological effects of tocilizumab in active rheumatoid arthritis (RA) patients. METHODS: Fourteen patients with active RA were enrolled in this study. The patients received tocilizumab 8 mg/kg intravenously every four weeks for 6 months. Disease activity, anemia-related factors including serum hepcidin-25, and hematological parameters were monitored at baseline and at 1, 3, and 6 months after the initiation of treatment. RESULTS: Significant reductions in tender joint count, swollen joint count, visual analogue scale, erythrocyte sedimentation rate (ESR), and C-reactive (CRP) protein plus reductions in a 28-joint disease activity score were observed within one month after the first tocilizumab treatment. These effects lasted throughout the six-month study period. In addition, significant improvements in anemia-related factors such as hepcidin-25, ferritin, iron, hemoglobin, red blood cell counts and mean corpuscular volume were observed during the treatment period. Hematological parameters were improved with reductions in counts for leukocytes, monocytes, neutrophils, and platelets. The lymphocyte counts and their subset numbers were unchanged. Changes in hepcidin levels showed significant correlation with changes in CRP, ESR, ferritin, hemoglobin and counts for red blood cells, leukocytes, and neutrophils during the treatment period. CONCLUSION: This study demonstrates that tocilizumab significantly and meaningfully reduces disease burden in patients with active RA. In addition, tocilizumab diminishes the levels of inflammatory anemia by inhibiting hepcidin production. These clinical data provide evidence of a favorable outcome from tocilizumab in RA.
Anemia*
;
Arthritis, Rheumatoid*
;
Blood Sedimentation
;
Erythrocyte Count
;
Erythrocyte Indices
;
Erythrocytes
;
Ferritins
;
Hepcidins*
;
Humans
;
Iron
;
Joints
;
Leukocytes
;
Lymphocyte Count
;
Monocytes
;
Neutrophils
8.Methylation of eukaryotic elongation factor 2 induced by basic fibroblast growth factor via mitogen-activated protein kinase.
Gyung Ah JUNG ; Bong Shik SHIN ; Yeon Sue JANG ; Jae Bum SOHN ; Seon Rang WOO ; Jung Eun KIM ; Go CHOI ; Kyung Mi LEE ; Bon Hong MIN ; Kee Ho LEE ; Gil Hong PARK
Experimental & Molecular Medicine 2011;43(10):550-560
Protein arginine methylation is important for a variety of cellular processes including transcriptional regulation, mRNA splicing, DNA repair, nuclear/cytoplasmic shuttling and various signal transduction pathways. However, the role of arginine methylation in protein biosynthesis and the extracellular signals that control arginine methylation are not fully understood. Basic fibroblast growth factor (bFGF) has been identified as a potent stimulator of myofibroblast dedifferentiation into fibroblasts. We demonstrated that symmetric arginine dimethylation of eukaryotic elongation factor 2 (eEF2) is induced by bFGF without the change in the expression level of eEF2 in mouse embryo fibroblast NIH3T3 cells. The eEF2 methylation is preceded by ras-raf-mitogen-activated protein kinase kinase (MEK)-extracellular signal-regulated kinase (ERK1/2)-p21(Cip/WAF1) activation, and suppressed by the mitogen-activated protein kinase (MAPK) inhibitor PD98059 and p21(Cip/WAF1) short interfering RNA (siRNA). We determined that protein arginine methyltransferase 7 (PRMT7) is responsible for the methylation, and that PRMT5 acts as a coordinator. Collectively, we demonstrated that eEF2, a key factor involved in protein translational elongation is symmetrically arginine-methylated in a reversible manner, being regulated by bFGF through MAPK signaling pathway.
Animals
;
Arginine
;
Cell Dedifferentiation
;
Cyclin-Dependent Kinase Inhibitor p21/genetics/metabolism
;
Elongation Factor 2 Kinase/*metabolism
;
Fibroblast Growth Factor 2/*metabolism
;
Fibroblasts/*metabolism/pathology
;
Flavonoids/pharmacology
;
MAP Kinase Signaling System/drug effects/genetics
;
Methylation
;
Mice
;
Mitogen-Activated Protein Kinases/antagonists & inhibitors
;
Myofibroblasts/pathology
;
NIH 3T3 Cells
;
Protein Methyltransferases/*metabolism
;
Protein-Arginine N-Methyltransferases/*metabolism
;
RNA, Small Interfering/genetics
9.Methylation of eukaryotic elongation factor 2 induced by basic fibroblast growth factor via mitogen-activated protein kinase.
Gyung Ah JUNG ; Bong Shik SHIN ; Yeon Sue JANG ; Jae Bum SOHN ; Seon Rang WOO ; Jung Eun KIM ; Go CHOI ; Kyung Mi LEE ; Bon Hong MIN ; Kee Ho LEE ; Gil Hong PARK
Experimental & Molecular Medicine 2011;43(10):550-560
Protein arginine methylation is important for a variety of cellular processes including transcriptional regulation, mRNA splicing, DNA repair, nuclear/cytoplasmic shuttling and various signal transduction pathways. However, the role of arginine methylation in protein biosynthesis and the extracellular signals that control arginine methylation are not fully understood. Basic fibroblast growth factor (bFGF) has been identified as a potent stimulator of myofibroblast dedifferentiation into fibroblasts. We demonstrated that symmetric arginine dimethylation of eukaryotic elongation factor 2 (eEF2) is induced by bFGF without the change in the expression level of eEF2 in mouse embryo fibroblast NIH3T3 cells. The eEF2 methylation is preceded by ras-raf-mitogen-activated protein kinase kinase (MEK)-extracellular signal-regulated kinase (ERK1/2)-p21(Cip/WAF1) activation, and suppressed by the mitogen-activated protein kinase (MAPK) inhibitor PD98059 and p21(Cip/WAF1) short interfering RNA (siRNA). We determined that protein arginine methyltransferase 7 (PRMT7) is responsible for the methylation, and that PRMT5 acts as a coordinator. Collectively, we demonstrated that eEF2, a key factor involved in protein translational elongation is symmetrically arginine-methylated in a reversible manner, being regulated by bFGF through MAPK signaling pathway.
Animals
;
Arginine
;
Cell Dedifferentiation
;
Cyclin-Dependent Kinase Inhibitor p21/genetics/metabolism
;
Elongation Factor 2 Kinase/*metabolism
;
Fibroblast Growth Factor 2/*metabolism
;
Fibroblasts/*metabolism/pathology
;
Flavonoids/pharmacology
;
MAP Kinase Signaling System/drug effects/genetics
;
Methylation
;
Mice
;
Mitogen-Activated Protein Kinases/antagonists & inhibitors
;
Myofibroblasts/pathology
;
NIH 3T3 Cells
;
Protein Methyltransferases/*metabolism
;
Protein-Arginine N-Methyltransferases/*metabolism
;
RNA, Small Interfering/genetics
10.Adult-to-Adult Living Donor Liver Transplantation.
Sung Gyu LEE ; Young Joo LEE ; Kwang Min PARK ; Hoon Bae JEON ; Shin HWANG ; Kang Hong LEE ; Rang Kee LEE ; Jung Joon LEE ; Jae Han JUNG ; Won Yong CHOI ; Jin Wook CHOI ; Chul Soo AHN ; Tae Yong HA ; Hoe Jung JUNG ; Byung Chan LEE ; Kyung Suck KOH ; Sang Hoon PARK ; Kyu Taek CHOI ; Yung Sang LEE ; Young Hwa CHUNG ; Dong Jin SUH ; Myung Hwan KIM ; Moon Gyu LEE ; Kyu Bo SUNG ; Mi Kyong KIM ; Hea Seon HA ; Pyung Chul MIN
Journal of the Korean Surgical Society 1998;55(5):719-725
BACKGROUNDS: Living-donor liver transplantation (LDLT) has been established as an efficacious option to resolve the shortage of cadaveric donor organs for pediatric recipients. This surgical innovation has significantly reduced the pretransplantation mortality for children, but the crisis of increasing scarcity of donor organs in our hospital has led us to extend LDLT to adult recipients. However, the extension of LDLT from pediatric recipients to adult recipients has been made only with limited success largely because of the inability of a relatively small-size left-lobe graft to meet the metabolic demands of an adult recipient. It has been postulated that a left-lobe graft smaller than 40% of the recipient's standard liver volume will not result in a successful adult-to-adult LDLT in chronic parenchymal liver disease. METHODS: From February 1997 to October 1997, 10 LDLTs, using 9 extended left-lobe grafts and 1 right-lobe graft, were performed on patients with end-stage parenchymal liver diseases (9 cases of B-hepatitis-induced cirrhosis with or without an associated hepatocellular carcinoma and 1 case of alcoholic cirrhosis) at the Department of Surgery, Asan Medical Center. The ratios of the graft to the standard liver volume of the recipients were in the range of 30% to 55%. RESULTS: All grafts showed immediate function, but delayed normalization of the serum total bilirubin was demonstrated in all recipients receiving left-lobe grafts. There were no mortalities and serious complications in donors. Two recipients died of sepsis 21 days and 40 days after transplantation, and 8 recipients (80%) are alive with good liver function at a median follow-up of 5.1 months (range 2~10 months). CONCLUSIONS: The aim of this article is to report our experience with adult-to-adult LDLT shows that a graft size greater than 30% of the recipient's standard liver volume is able to meet the metabolic demands of adult recipients with chronic parenchymal liver disease and that LDLT might open a new donor pool for adult recipients when the supply of cadaveric organs is severely restricted.
Adult
;
Alcoholics
;
Bilirubin
;
Cadaver
;
Carcinoma, Hepatocellular
;
Child
;
Chungcheongnam-do
;
Fibrosis
;
Follow-Up Studies
;
Humans
;
Liver Diseases
;
Liver Transplantation*
;
Liver*
;
Living Donors*
;
Mortality
;
Sepsis
;
Tissue Donors
;
Transplants